Additionally, Turner Syndrome patients exhibit a clustering of acquired cardiovascular disease risk factors, including increased rates of hypertension, glucose intolerance, obesity and dyslipidemia, which are also impacted by treatment regimens including growth hormone (GH) and estrogen [1]. The gene discussed is GH1; the disease is obesity disorder.